According to sources at the NIH, five individuals have been scheduled to attend the meeting as of last Friday. There is no indication at this time that a public forum will take place. LymeNet Newsletter Contributing Editor Carl Brenner is scheduled to represent the Lyme Disease Resource Center. Lyme disease researchers, physicians, and patients are encouraged to communicate their thoughts on LD research to Dr. Varmus. Letters should contain only one or two clear points and should be as short as possible.
Long letters containing many ideas are generally less effective.
All those interested in LD are invited to attend. The majority would use amoxicillin or doxycycline to treat EM in children or adults, respectively. Nearly all would use ceftriaxone for meningitis, and half would use it to treat Lyme arthritis or Bell's palsy. Physicians differed markedly in the duration of therapy they would prescribe. Results of studies using direct antigen detection suggest that seronegative Lyme borreliosis is not rare and support the hypothesis that Borrelia antigens can persist in humans.